Get an SMS notification of your lab order and complete your test at a participating clinic.
It's that easy.
We combine microneedle sample collection with automation, allowing for quality results in just minutes with minimal hands-on time.
Have a condition that requires very frequent testing? Skip the pharmacy. We'll bring the lab directly to your home.
An API-enabled order, analysis and reporting platform built for virtual care providers.
Health providers and researchers can use our API or web portal to order labs for their patients. Patients are notified via SMS, where they can seamlessly coordinate test completion.
Reports are directly fed to the provider's EMR along with insights such as trends deemed important by our context engine.
Population level reports enable discovery of patterns that can guide development of new care strategies.
Three steps, ten minutes: microneedle sample to molecular insights.
Inserting the cartridge starts a 3-step calibration process that ensures clinical-grade results.
Pressing the button on the microneedle collector starts virtually painless blood collection.
Removing the tube and inserting into the cartridge begins blood sample analysis.
Enabled by electrochemical biosensor technology.
Sample mixed with detection antibody and electron generator
Protein-antibody complex introduced to capture antibody on biosensor
Electron transfer measured by biosensor
Antibody tests: Antibodies in sample bind to biosensor and reduce electron transfer
Small molecule tests: Drug in sample displaces antibody from biosensor and increases electron transfer
Molecules in sample react with biosensor, resulting in charge accumulation or electron transfer
Working with industry to accelerate the transition to patient-centric healthcare.
Dr. Dan Bensimhon, MD
InnaMed’s patient-centric solution will revolutionize how we treat heart failure, enabling us to titrate meds more aggressively and provide a higher level of care at home. InnaMed’s cloud platform will also help with our clinical research efforts by improving patient adherence, retention, and satisfaction.
Dr. Shawn McCandless, MD
Real-time at-home blood testing for patients with inborn errors of metabolism is a significant advantage over the current standard of care. It allows for safe, convenient monitoring and tighter metabolic control for these high-risk patients.
Dr. David Karpf, MD
InnaMed's HomeLab platform holds promise to fulfill some of the biggest unmet needs for patients with an array of metabolic disorders, enabling precision medicine and optimal management of therapies.